Published in J Clin Oncol on May 01, 1985
The role of endothelial cell injury in thrombotic microangiopathy. Am J Kidney Dis (2010) 1.10
Hemolytic uremic syndrome following the infusion of oxaliplatin: case report. BMC Clin Pharmacol (2006) 1.00
Chemotherapy-associated renal dysfunction. Nat Rev Nephrol (2009) 0.95
Slow, but complete, resolution of mitomycin-induced refractory thrombotic thrombocytopenic purpura after rituximab treatment. Korean J Hematol (2011) 0.82
Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II. J Natl Med Assoc (1994) 0.80
Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy. J Transl Med (2012) 0.78
Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report. Med Oncol (2013) 0.78
Thrombotic thrombocytopenic purpura following salvage chemotherapy with paclitaxel, ifosfamide and cisplatin in a patient with a refractory germ cell tumor: A case report and review of the literature. Oncol Lett (2015) 0.75
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J (1969) 3.37
Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J (1970) 2.91
Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol (1989) 2.33
Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet (1971) 2.22
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med (1980) 1.95
Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med (1992) 1.90
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol (2001) 1.87
Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies. Ann Intern Med (1974) 1.87
Effects of streptozotocin on carbohydrate and lipid metabolism in the rat. Endocrinology (1971) 1.86
Immunologic function and survival in hemodialysis patients. Kidney Int (1998) 1.82
Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol (1998) 1.80
The specificity of surface membrane immunofluorescence in human malignant melanoma. Int J Cancer (1972) 1.75
The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man. Clin Pharmacol Ther (1970) 1.54
Chemotherapeutic alteration of small intestinal morphology and function: a progress report. J Clin Gastroenterol (1979) 1.54
Circulating immune complexes in schistosomiasis due to Schistosoma mansoni. Br Med J (1975) 1.51
Presence of anti-pituitary hormone antibodies in patients with empty sella syndrome and pituitary tumours. Clin Endocrinol (Oxf) (1993) 1.49
Islet cell tumors: current concepts and management. Ann Intern Med (1973) 1.48
The use of drugs in combination for the treatment of cancer: rationale and results. N Engl J Med (1973) 1.43
Immunosuppressive and cytotoxic chemotherapy: long-term complications. Ann Intern Med (1975) 1.40
Lupus vulgaris and Hodgkin's disease. Arch Dermatol (1972) 1.39
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group. J Clin Oncol (1990) 1.36
Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Intern Med (1976) 1.33
Pancreatic cholera: benefical effects of treatment with streptozotocin. N Engl J Med (1975) 1.32
Cyclical combination chemotherapy for advanced breast carcinoma. Br Med J (1974) 1.26
The toxicity of Escherichia coli L-asparaginase. Cancer Res (1969) 1.25
Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited. Blood (1976) 1.22
Panel: cancer of the pancreas. Am J Surg (1978) 1.21
The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity. Cancer Res (1967) 1.20
Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem (1992) 1.18
5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. Cancer (1979) 1.17
Epstein-Barr virus shedding by astronauts during space flight. Brain Behav Immun (2005) 1.16
Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomata. Br J Cancer Suppl (1975) 1.15
Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide. Proc Soc Exp Biol Med (1971) 1.14
Herpes simplex type 2 encephalitis concurrent with known cerebral metastases. Acta Neuropathol (1979) 1.13
Streptozotocin: depression of mouse liver pyridine nucleotides. Cancer Res (1968) 1.13
Cachexia of malignancy: potential role of insulin in nutritional management. Cancer (1979) 1.11
Target role of Langerhans cells in mycosis fungoides: transmission and immuno-electron microscopic studies. J Cutan Pathol (1979) 1.10
Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation. Cancer Res (1983) 1.08
Cutaneous seeding of pancreatic cancer by skinny-needle aspiration biopsy. Arch Intern Med (1980) 1.05
Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells. Proc Natl Acad Sci U S A (1987) 1.03
Dyadic relationship conflict, gender, and mortality in urban hemodialysis patients. J Am Soc Nephrol (2000) 1.03
Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine (2001) 1.02
Liposomal protection of adriamycin-induced cardiotoxicity in mice. Cancer Res (1980) 1.02
Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol (1992) 1.02
5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. J Clin Oncol (1984) 1.01
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998). Cancer (1974) 1.01
Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma. Blood (1974) 1.00
Streptozotocin diabetes--further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver. Biochem Pharmacol (1973) 1.00
Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice. Magnes Res (1996) 0.99
Plasma glucose levels in normal and adrenalectomized mice treated with streptozotocin and nicotinamide. Diabetes (1968) 0.99
Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. Circ Res (1994) 0.98
Microvascular assessment of burn depth conversion during varying resuscitation conditions. J Burn Care Rehabil (2001) 0.97
HIV-associated immune-mediated renal disease. Kidney Int (1993) 0.97
Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes. Cancer Res (1985) 0.97
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report. Cancer (1978) 0.96
Hyperdibasicaminoaciduria, hyperammonemia, and growth retardation: Treatment with arginine, lysine, and citrulline. J Pediatr (1975) 0.96
CEA (carcinoembryonic antigen): its role as a marker in the management of cancer. J Cancer Res Clin Oncol (1981) 0.96
Phase-II trial of tamoxifen in advanced breat cancer. Cancer Chemother Pharmacol (1979) 0.95
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy. Cancer (1975) 0.95
Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. A Mid-Atlantic Oncology Program study. Cancer (1991) 0.95
Stereoselective reduction of pyruvate by sodium borohydride catalyzed by pyruvate kinase. Biochim Biophys Acta (1973) 0.95
Doxorubicin-induced chronic cardiotoxicity and its protection by liposomal administration. Cancer Res (1982) 0.94
Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial. Cancer (1978) 0.94
Immunological associations of the halo naevus with cutaneous malignant melanoma. Br J Dermatol (1973) 0.94
Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition. Mol Cell Biochem (1994) 0.94
Presidential address: the plight of clinical cancer research. J Clin Oncol (1984) 0.94
5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas. Cancer (1980) 0.93
Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer. Cancer (1978) 0.93
A system of immunofluorescence in the study of tumour cells. Rev Eur Etud Clin Biol (1970) 0.93
Unilateral megalencephaly, cerebral cortical dysplasia, neuronal hypertrophy, and heterotopia: cytomorphometric, fluorometric cytochemical, and biochemical analyses. Acta Neuropathol (1979) 0.93
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med (1976) 0.93
Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes (1990) 0.92
Possible explanation for loss of detectable antibody in patients with disseminated malignant melanoma. Nature (1971) 0.92
Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res (1978) 0.92
Phase I clinical trial of spirogermanium. Cancer Treat Rep (1981) 0.91
The 2003 Carl A Moyer Award: real-time metabolic monitors, ischemia-reperfusion, titration endpoints, and ultraprecise burn resuscitation. J Burn Care Rehabil (2004) 0.91
Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer. Blood (1978) 0.91
Nitrosourea interaction with chromatin and effect on poly(adenosine diphosphate ribose) polymerase activity. Cancer Res (1979) 0.91
Separation of two distinct tumor-associated antibodies in the serum of melanoma patients. J Natl Cancer Inst (1972) 0.91
The role of chemotherapy in the management of gastric and pancreatic carcinomas. Semin Oncol (1985) 0.90
Update on topical cyclosporin A. Background, immunology, and pharmacology. Cornea (1990) 0.90
Ia antigens on indeterminate cells of the epidermis: immunoelectronmicroscopic studies of surface antigens. Br J Dermatol (1979) 0.90
Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters. Cancer Treat Rep (1976) 0.89
Sorbent removal of adriamycin in vitro and in vivo. Cancer Treat Rep (1980) 0.89
Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade. J Mol Cell Cardiol (1997) 0.89
Hyperphosphatemia and hypocalcemia in Burkitt lymophoma. Complications of chemotherapy. Arch Intern Med (1975) 0.89
Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma. Cancer (1981) 0.89
Current management of advanced and locally unresectable gastric carcinoma. Cancer (1982) 0.89
Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets. Mol Pharmacol (1983) 0.89
Renal tumorigenic action of streptozotocin (NSC-85998) in rats. Cancer Chemother Rep (1968) 0.89
Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int (1990) 0.88
Characterization of the fertilization antigen 1 for the development of a contraceptive vaccine. Proc Natl Acad Sci U S A (1986) 0.88
Immune complexes in human melanoma: a consequence of deranged immune regulation. Scand J Immunol (1976) 0.88
Immune complex arthritis in a patient with Schistosoma mansoni infection. Arthritis Rheum (1986) 0.88
Computerised axial tomography for diagnosis of pancreatic cancer. Lancet (1976) 0.87
Animal toxicology for early clinical trials with anticancer agents. Cancer Clin Trials (1981) 0.87
Chemotherapy of large intestinal carcinoma. Current results and future prospects. Cancer (1975) 0.87
Ovarian carcinoma metastatic to the diaphragm--frequently undiagnosed at laparotomy. A preliminary report. Am J Obstet Gynecol (1973) 0.87
Chemotherapy of colorectal carcinoma. Semin Oncol (1976) 0.87
Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide. J Clin Invest (1974) 0.87